Should splenectomy be performed for hepatitis C patients undergoing living-donor liver transplantation?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 6, 2007, Pages 959-960

  Tashiro, Hirotaka ^a   Itamoto, Toshiyuki ^a   Ohdan, Hideki ^a   Fudaba, Yasuhiro ^a   Kohashi, Toshihiko ^a   Amano, Hironobu ^a   Ishiyama, Kohei ^a   Takahashi, Shoichi ^a   Aikata, Hiroshi ^a   Chayama, Kazuaki ^a   Arihiro, Koji ^a   Asahara, Toshimasa ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

CYTOPENIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; LIVING DONOR; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PSYCHOSIS; RECURRENT DISEASE; SPLENECTOMY; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 34250326789     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04951.x     Document Type: Letter

References (7)

1. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002 122 : 889 96.
2. Heydtmann M, Freshwater D, Dudley T et al. Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation. Am. J. Transplant. 2006 6 : 825 33.
3. Shergill AK, Khalili M, Straley S et al. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am. J. Transplant. 2005 5 : 118 24.
4. Kishi Y, Sugawara Y, Akamatsu N et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin. Transplant. 2005 19 : 769 72.
5. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996 24 : 289 93.
6. Neff GW, Montalbano M, O'Brien CB et al. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Transplantation 2004 78 : 1303 7.
7. Settmacher U, Nussler NC, Glanemann M et al. Venous complications after orthotopic liver transplantation. Clin. Transplant. 2000 14 : 235 41.